Market Overview

Goldman Sachs Downgrades Cepheid from Buy to Neutral, Announces PT of $32

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CPHD

DateFirmActionFromTo
Feb 2016Stifel NicolausMaintainsBuy
Feb 2016BairdMaintainsOutperform
Jan 2016Avondale PartnersInitiates Coverage onMarket Outperform

View More Analyst Ratings for CPHD
View the Latest Analyst Ratings

Posted-In: Downgrades Price Target Initiation Analyst Ratings

 

Related Articles (CPHD)

Get Benzinga's Newsletters